{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T09:55:16Z","timestamp":1753437316533,"version":"3.40.5"},"reference-count":40,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T00:00:00Z","timestamp":1640131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>Hypothyroxinaemia might be easily ignored, because attention is typically paid to individuals with elevated thyroid stimulating hormone (TSH). In this study, we aimed to evaluate the association of oxcarbazepine use as adjuvant for treatment of schizophrenia with hypothyroxinaemia and central set point of thyroid homeostasis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective cohort study was conducted in the Second Affiliated Hospital of Xinxiang Medical University. Inpatients with a diagnosis of schizophrenia admitted between January 2016 and October 2019 with normal thyroid function at admission were included. Oxcarbazepine use was the exposure measure. Newly developed hypothyroxinaemia was the primary outcome measure and parameters of thyroid homeostasis central set point as measured by TSH index and thyroid feedback quantile\u2010based index (TFQI) were the secondary outcome measures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 1207 eligible patients were included. The occurrence of hypothyroxinaemia in patients who received oxcarbazepine was higher (35\/107, 32.7%) than in those patients who did not (152\/1099, 13.8%), with adjusted relative risk of 2.24 and 95% confidence interval of 1.57 and 3.17. Oxcarbazepine use was associated with greater reduction in TSH index (adjusted \u03b2\u00a0\u22120.33 and 95% confidence interval \u22120.48, \u22120.19) and TFQI (adjusted \u03b2\u00a0\u22120.24 and 95% confidence interval \u22120.31, \u22120.16).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Oxcarbazepine use was independently associated with increased risk of developing hypothyroxinaemia, and greater reduction in TSH index and TFQI, suggesting that impaired central set point of thyroid homeostasis might be involved in the mechanism of oxcarbazepine\u2010induced hypothyroxinaemia.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.15163","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T20:09:00Z","timestamp":1638389340000},"page":"2297-2305","source":"Crossref","is-referenced-by-count":4,"title":["Oxcarbazepine was associated with risks of newly developed hypothyroxinaemia and impaired central set point of thyroid homeostasis in schizophrenia patients"],"prefix":"10.1111","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1518-0396","authenticated-orcid":false,"given":"Desheng","family":"Zhai","sequence":"first","affiliation":[{"name":"Xinxiang Medical University, The Second Affiliated Hospital  Xinxiang China"},{"name":"School of Public Health Xinxiang Medical University  Xinxiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinni","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Public Health Xinxiang Medical University  Xinxiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoqiang","family":"Guo","sequence":"additional","affiliation":[{"name":"School of Public Health Xinxiang Medical University  Xinxiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Retnakaran","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism University of Toronto  Toronto Canada"},{"name":"Lunenfeld\u2010Tanenbaum Research Institute, Mount Sinai Hospital  Toronto Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songyin","family":"Gao","sequence":"additional","affiliation":[{"name":"Zhumadian Mental Health Center  Zhumadian China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Xinxiang Medical University, The Second Affiliated Hospital  Xinxiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Hao","sequence":"additional","affiliation":[{"name":"Xinxiang Medical University, The Second Affiliated Hospital  Xinxiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Xinxiang Medical University, The Second Affiliated Hospital  Xinxiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[{"name":"School of Pharmacy Xinxiang Medical University  Xinxiang China"},{"name":"Xinxiang Key Laboratory of Clinical psychopharmacology Xinxiang Medical University  Xinxiang China"},{"name":"Henan International Joint Laboratory of Non\u2010Invasive Neuro\u2010modulation Xinxiang Medical University  Xinxiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi Wu","family":"Wen","sequence":"additional","affiliation":[{"name":"OMNI Research Group, Clinical Epidemiology Program Ottawa Hospital Research Institute  Ottawa Canada"},{"name":"School of Epidemiology and Public Health University of Ottawa Faculty of Medicine  Ottawa Canada"},{"name":"Department of Obstetrics, Gynecology, and Newborn Care University of Ottawa Faculty of Medicine  Ottawa Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,12,22]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1808803"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300273"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30132-4"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300023"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0601"},{"volume-title":"Chinese National Guidelines of Diagnosis and Treatment for Schizophrenia","year":"2015","author":"Zhao JP","key":"e_1_2_12_7_1"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.4.336"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e31823429a7"},{"key":"e_1_2_12_10_1","article-title":"Carbamazepine for schizophrenia","volume":"2014","author":"Leucht S","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.6.1130-a"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00821.x"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13026"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200X.2007.02456.x"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1995.tb01619.x"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.042007930.x"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2004.26003.x"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1901214"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30703-1"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.47"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-008-0122-6"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1981.03310260021020"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14928"},{"key":"e_1_2_12_24_1","unstructured":"SPINA Thyr software for structure parameter inference approach of thyroid function. In http:\/\/spina.medical-cybernetics.de"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00057"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00163"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14949"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03534.x"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1410"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12262"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2020.107555"},{"key":"e_1_2_12_32_1","unstructured":"In https:\/\/www.drugs.com\/sfx\/oxcarbazepine-side-effects.html"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03530430039036"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2005.08.032"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/0883073820962926"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n1019e"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0111"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2018.09.014"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-014-0279-7"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1912672"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.11040631"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.15163","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcp.15163","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.15163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T22:29:43Z","timestamp":1693002583000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.15163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,22]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1111\/bcp.15163"],"URL":"https:\/\/doi.org\/10.1111\/bcp.15163","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"type":"print","value":"0306-5251"},{"type":"electronic","value":"1365-2125"}],"subject":[],"published":{"date-parts":[[2021,12,22]]}}}